Difficulty: Medium
Average Score: 80%
Practice
Which drug does not influence leukopoiesis?
Correct answer
B
Rationale
The correct answer is B) Erythropoietin because it does not influence leukopoiesis. Erythropoietin is a hormone primarily involved in stimulating red blood cell production (erythropoiesis) in the bone marrow and does not have a direct impact on white blood cell production (leukopoiesis).
A) Filgrastim is a drug that stimulates the production of white blood cells, specifically neutrophils, and is commonly used to prevent neutropenia in patients undergoing chemotherapy.
C) Doxorubicin is an anthracycline chemotherapy drug that can suppress leukopoiesis, leading to decreased white blood cell counts as a side effect.
D) Methotrexate is an antimetabolite drug that also affects leukopoiesis by inhibiting the production of white blood cells, particularly lymphocytes.
Understanding the effects of different drugs on hematopoiesis is crucial in pharmacology, especially in the context of managing patients undergoing chemotherapy or with hematological disorders. It is essential for healthcare providers to be able to differentiate between drugs that impact different blood cell lineages to provide appropriate and effective treatment while minimizing adverse effects.
A) Filgrastim is a drug that stimulates the production of white blood cells, specifically neutrophils, and is commonly used to prevent neutropenia in patients undergoing chemotherapy.
C) Doxorubicin is an anthracycline chemotherapy drug that can suppress leukopoiesis, leading to decreased white blood cell counts as a side effect.
D) Methotrexate is an antimetabolite drug that also affects leukopoiesis by inhibiting the production of white blood cells, particularly lymphocytes.
Understanding the effects of different drugs on hematopoiesis is crucial in pharmacology, especially in the context of managing patients undergoing chemotherapy or with hematological disorders. It is essential for healthcare providers to be able to differentiate between drugs that impact different blood cell lineages to provide appropriate and effective treatment while minimizing adverse effects.